Helen Moore

1.7k total citations
61 papers, 1.1k citations indexed

About

Helen Moore is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Helen Moore has authored 61 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 9 papers in Molecular Biology and 7 papers in Genetics. Recurrent topics in Helen Moore's work include Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Cancer Genomics and Diagnostics (4 papers). Helen Moore is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Cancer Genomics and Diagnostics (4 papers). Helen Moore collaborates with scholars based in United States, Australia and United Kingdom. Helen Moore's co-authors include David Whitmore, Suzanne Lenhart, Khalid Tobal, Heddy Zola, Mamta Garg, John A. Liu Yin, Jim Vaught, Nicole C. Lockhart, Urszula Ledzewicz and Carolyn C. Compton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Helen Moore

58 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen Moore United States 18 303 208 199 173 151 61 1.1k
Corrie Painter United States 21 365 1.2× 142 0.7× 120 0.6× 385 2.2× 55 0.4× 44 1.9k
Hannah Chang United States 8 1.2k 4.1× 249 1.2× 54 0.3× 132 0.8× 120 0.8× 14 2.1k
Li Shi China 21 620 2.0× 81 0.4× 65 0.3× 557 3.2× 92 0.6× 140 1.8k
Amanda Jackson United States 19 665 2.2× 223 1.1× 30 0.2× 133 0.8× 27 0.2× 43 1.5k
Ollivier Hyrien United States 23 428 1.4× 29 0.1× 70 0.4× 325 1.9× 31 0.2× 79 1.7k
Elena Soto‐Vega Mexico 14 87 0.3× 74 0.4× 57 0.3× 178 1.0× 43 0.3× 43 1.0k
Mary E. Sehl United States 21 1.0k 3.4× 71 0.3× 53 0.3× 103 0.6× 39 0.3× 52 2.0k
Augustine Rajakumar United States 34 446 1.5× 522 2.5× 71 0.4× 1.2k 6.8× 15 0.1× 73 3.7k
Kewei Ma China 23 1.1k 3.5× 64 0.3× 41 0.2× 303 1.8× 131 0.9× 131 2.5k
Helen Parry United Kingdom 20 358 1.2× 44 0.2× 58 0.3× 268 1.5× 28 0.2× 50 1.4k

Countries citing papers authored by Helen Moore

Since Specialization
Citations

This map shows the geographic impact of Helen Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Moore more than expected).

Fields of papers citing papers by Helen Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Moore. The network helps show where Helen Moore may publish in the future.

Co-authorship network of co-authors of Helen Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Moore. A scholar is included among the top collaborators of Helen Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Moore. Helen Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vasilopoulos, Terrie, et al.. (2025). Quantitative methods to improve bivalirudin dosing in pediatric cardiac ICU patients. Perfusion. 40(8). 1751–1761.
2.
Ledzewicz, Urszula, et al.. (2023). Determining optimal combination regimens for patients with multiple myeloma. European Journal of Pharmaceutical Sciences. 187. 106492–106492. 4 indexed citations
3.
4.
Lee, Yeh Chen, Hao‐Wen Sim, Tanya Chawla, et al.. (2022). Interobserver and intraobserver variability of RECIST assessment in ovarian cancer. International Journal of Gynecological Cancer. 32(5). 656–661. 7 indexed citations
5.
Torvaldsen, Siranda, et al.. (2021). Alternatives to low birthweight as a population-level indicator of infant and child health. Public Health Research & Practice. 32(1). 1 indexed citations
6.
Moore, Helen. (2018). How to mathematically optimize drug regimens using optimal control. Journal of Pharmacokinetics and Pharmacodynamics. 45(1). 127–137. 34 indexed citations
7.
Gallaher, Jill, Marissa Renardy, Nessy Tania, et al.. (2018). Methods for determining key components in a mathematical model for tumor–immune dynamics in multiple myeloma. Journal of Theoretical Biology. 458. 31–46. 14 indexed citations
8.
Moore, Helen, Lewis C. Strauss, & Urszula Ledzewicz. (2018). Optimization of combination therapy for chronic myeloid leukemia with dosing constraints. Journal of Mathematical Biology. 77(5). 1533–1561. 11 indexed citations
9.
Moore, Helen & David Whitmore. (2014). Circadian Rhythmicity and Light Sensitivity of the Zebrafish Brain. PLoS ONE. 9(1). e86176–e86176. 82 indexed citations
10.
Zheng, Yanyan, et al.. (2013). Mathematical Modeling of Tumor Cell Proliferation Kinetics and Label Retention in a Mouse Model of Lung Cancer. Cancer Research. 73(12). 3525–3533. 7 indexed citations
12.
Moore, Helen, et al.. (2013). Circadian Clock Regulation of the Cell Cycle in the Zebrafish Intestine. PLoS ONE. 8(8). e73209–e73209. 42 indexed citations
13.
Scandol, James P. & Helen Moore. (2012). Health Statistics NSW: getting the right balance between privacy and small numbers in a web-based reporting system. New South Wales Public Health Bulletin. 23(2). 1–1. 1 indexed citations
14.
Vaught, Jim, John Rogers, Mark D. Lim, et al.. (2011). An NCI Perspective on Creating Sustainable Biospecimen Resources. JNCI Monographs. 2011(42). 1–7. 87 indexed citations
15.
Rubinstein, Yaffa, Stephen C. Groft, Ronald Christensen, et al.. (2010). Creating a global rare disease patient registry linked to a rare diseases biorepository database: Rare Disease-HUB (RD-HUB). Contemporary Clinical Trials. 31(5). 394–404. 71 indexed citations
16.
Moore, Helen, et al.. (2007). Optimal control of treatment in a mathematical model of chronic myelogenous leukemia. Mathematical Biosciences. 210(1). 143–156. 87 indexed citations
17.
Moore, Helen, et al.. (2005). Laying foundations for health: food provision for under 5s in day care. Appetite. 44(2). 207–213. 42 indexed citations
18.
Moore, Helen & Weiqing Gu. (2005). A mathematical model for treatment-resistant mutations of HIV. Mathematical Biosciences & Engineering. 2(2). 363–380. 7 indexed citations
20.
Seshadri, R., C. Matthews, Helen Moore, & Heddy Zola. (1984). T-cell growth factor production by adult, but not childhood acute lymphoblastic leukaemic cells. Annals of Hematology. 49(6). 441–446. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026